AUA guidelines for BPH endorse combination therapy

June 1, 2003

Chicago-Recognition of combination drug therapy for selected patients with benign prostatic hyperplasia represents one of several key changes in clinical management embraced by AUA in the organization's first-ever clinical guidelines for BPH.